- +1-315-215-1633
- sales@thebrainyinsights.com
The global atopic dermatitis market is expected to grow from USD 15.26 billion in 2023 to USD 33.26 billion by 2033, at a CAGR of 8.1% from 2024-2033. The Asia Pacific is expected to grow the fastest during the forecast period. Eczema, also known as atopic dermatitis, is a skin condition that causes irritation, inflammation, and redness. The growing incidence of this ailment is positively impacting market expansion. Factors such as greater awareness regarding skin conditions, a pressing demand for prompt diagnosis, and increasing interest in biological therapies are propelling business development forward. The emergence of new medical technologies and innovative procedures is anticipated to fuel growth within the global atopic dermatitis market. The growing use of harsh soaps, shampoos, and hand wash contributes to various skin conditions such as eczema. As a result, significant players in the market are striving to develop advanced solutions for addressing atopic dermatitis by creating moisturizers and ointments with increased healing capabilities.
An individual with atopic dermatitis experiences the impulse to scratch their skin because itching is so terrible for the body or the skin. Atopic dermatitis is also known as eczema. Any area of the body, primarily the epidermis, becomes extremely itchy, red, and dry. Dry weather, damp climate, metal allergies, food allergens, and personal care products with chemicals are just a few causes of skin itchiness. However, atopic dermatitis is most commonly found in patients with a family history of the same. Allergens also trigger it in personal care products, cosmetics, metals or foods. Environmental triggers like dampness in the air and dry and cold weather can also cause atopic dermatitis. Atopic dermatitis can be restricted to one part of the body, or it can happen to multiple parts of the body. It usually occurs behind the knee, arms or between toes. When the condition is not too severe, atopic dermatitis can be self-treated by avoiding allergens, scratching, and keeping the skin clean and hydrated. Pruritus therapies or biologics are the names of the drugs used to treat atopic dermatitis. Atopic dermatitis can be self-diagnosed and treated with a few over-the-counter drugs available in the market, like corticosteroid creams, calcineurin inhibitors, emollients/moisturizers, and antibiotics. Atopic dermatitis can be managed by avoiding chemical personal care and cosmetics, scratching, moisturizing the skin and staying hydrated. Pruritus therapies or biologics are the names of the drugs used to treat atopic dermatitis. Among the drugs that can lessen the discomfort of atopic dermatitis are topical steroids, antihistamines, corticosteroid creams, calcineurin inhibitors, emollients/moisturizers, antibiotics, IL-4 and PDE4 Inhibitors and others. Antihistamines, for instance, are used to treat atopic contact dermatitis, which is typically brought on by an allergen such as a metal like nickel.
Get an overview of this study by requesting a free sample
November 2022 - The terms of the marketing authorization for LEO Pharma's Adtralza have been modified to include the treatment of adolescent patients between the ages of 12 and 17. The conditions for treatment include patients who have moderate-to-severe atopic dermatitis (AD) and are candidates for systemic therapy. This change has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission (EC). The timing of the approval is crucial since, in the UK, 6% of adolescents in the newly approved age range have atopic dermatitis or one out of every five kids. There is a significant unmet need to assist patients with moderate-to-severe AD to manage AD with well-tolerated and efficient medications because moderate-to-severe AD has been found to take a physical, psychosocial, and emotional toll on adolescent patients. The phase 3 ECZTRA 6 trial data are the basis for the EC and MHRA approvals, which are valid in all European Union member states.
November 2022 - According to two phases and three trials, roxolitinib cream showed efficacy and tolerability in patients with atopic dermatitis over 44 weeks of as-needed treatment. In two double-blind phases, three studies of ruxolitinib for treating AD, long-term safety (LTS) and effectiveness data were evaluated. Patients had to be at least 12 years old, have had AD for more than two years, and have an IGA score of 2 or 3. Patients had 3% to 20% of their body's surface affected, excluding the scalp. After 44-week LTS treatment, the researchers claim that the condition was under control. 74.1% to 77.8% of patients received an IGA score of 0/1.
The growing incidence of skin disorders – About 900 million people worldwide have some sort of skin disease, according to a World Health Organization report on the rising prevalence of skin diseases in 2018. Atopic dermatitis is amongst the top skin conditions that equally affect both males and females. The underlying causes of atopic dermatitis are not known. However, an individual suffering from the condition, more often than not, has a family history of the same. The condition is triggered after the skin comes into contact with certain chemicals used in personal care products or certain environmental factors, such as extremely dry winters. Numerous skin illnesses and diseases are now more common among the world's population due to the increasing incidence of harsh environmental conditions. For instance, the extremely dry winters are one of the most common causes that trigger atopic dermatitis. People with atopic dermatitis are also rising as chemicals are used more frequently in personal care and cosmetics. The disease's rising prevalence will drive the global atopic dermatitis market. The market will grow due to people becoming more knowledgeable about atopic dermatitis, its causes, and potential treatments.
Inadequate understanding of the causes of atopic dermatitis – The underlying triggers or exact causes can range from food allergies and chemical allergens to family history and environmental conditions. The underlying evidence about whom the disease affects the most and how it is diagnosed or differentiated from other skin conditions is insufficient. More needs to be done for the patient population. The lack of proper understanding can restrict the market's growth as high costs are poured into developing drugs that may become ineffective or cause undesirable and severe side effects. This eventually hampers brand reputation by increasing product recalls and further limiting the global atopic dermatitis market’s growth.
Market players are developing novel biologics, and advanced treatment options - The increased need for atopic dermatitis medicines has prompted private companies to spend more money on developing novel drugs and therapies. Due to the increasing prevalence of skin illnesses and disorders worldwide, prominent market participants have developed promising and efficient medications to capitalize on the expanding atopic dermatitis market. Furthermore, the rising incidence and prevalence of atopic dermatitis due to cosmetics and personal care allergens or environmental triggers have convinced regulatory bodies to speed up drug approvals to offer citizens novel healthcare services. The market for atopic dermatitis treatments will expand due to regulatory approvals becoming more uniform and efficient. The development of the market will also be fueled by numerous mergers, acquisitions, and partnerships for developing medicines. The favourable reimbursement policies initiated by fiscal bodies will also expand the market in the future.
Stringent regulatory approvals and guidelines – The pharmaceutical and healthcare sector are subject to extremely strict rules and regulations, given their sensitive and crucial nature in the global economy and the direct impact it has on their consumers. For instance, approval and introduction of a novel drug without proper trials and checks can lead to undesirable consequences that can be fatal to consumers. As much as it is important to fast-track approval processes, it is equally vital to thoroughly check the risks and benefits associated with these drugs to safeguard consumer interests. As a result, strict regulations apply to the testing, production, distribution, and consumption of atopic dermatitis drugs, therapies and treatments. The government's strict controls will hamper the market's expansion.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region emerged as the largest global atopic dermatitis market, with a 42.4% market revenue share in 2023. The United States of America dominates the North American market and is anticipated to continue its dominance during the forecast period. The development of effective and promising drugs/therapies for treating atopic dermatitis, given the presence of significant and top market players in the region, facilitates the market's growth. The North American market will be driven by the rising private capital investment in the research & development of new treatments to address the expanding demand for atopic dermatitis treatments. The market for atopic dermatitis will benefit from favourable government policies supporting expanding the pharmaceutical and healthcare industries. The well-established healthcare system makes treatments accessible and inexpensive for the populace, which supports market growth. Due to the government's increased spending on the healthcare industry due to the pandemic, the Asia Pacific market is anticipated to grow during the forecast period. Major participants in the atopic dermatitis treatment market will be drawn to the region, fueling its growth in the projected period with the development of the healthcare infrastructure and the country's sizable population.
North America Region Atopic Dermatitis Market Share in 2023 - 42.4%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The product type segment is divided into corticosteroids, calcineurin inhibitors, emollients/moisturizers, antibiotics, IL-4 and PDE4 Inhibitors, and others. The corticosteroids segment dominated the market with a revenue share of 30.2% in 2023. An example of an anti-inflammatory medicine is corticosteroids. They are used to soothe the patient and lessen inflammation. Common corticosteroids include cortisone, prednisolone, dexamethasone, and hydrocortisone. Additionally, corticosteroids lessen allergic responses, swelling, itching, and redness. They are applied to numerous types of atopic dermatitis. Because of their adaptability and broad applicability, corticosteroids are a common atopic dermatitis treatment, which accounts for their market domination. They are supplied without a prescription at several drug stores. The rising awareness about corticosteroids and their increased accessibility will further the market segment's development.
The route of administration segment is divided into oral, topical, and parenteral. The topical segment dominated the market with a market share of 54.3% in 2023. "Topical medication" refers to drugs applied directly to the skin. Typically, they are sold as creams, gels, foams, and lotions. Topical therapies are preferable since atopic dermatitis is a skin ailment that results in irritation and discomfort on the skin's outer surface. One of the factors contributing to topical drugs' commercial domination is the simplicity and adaptability of their use. The topical route of administration allows for the avoidance of the negative effects.
The distribution channel segment is divided into hospital pharmacies, online pharmacies, retail pharmacies, and others. The retail pharmacies segment dominated the market with a market share of 46.4% in 2023. The increasing number of supermarket pharmacies facilitates the expansion of the industry. Drugs for atopic dermatitis that don't require a prescription are widely available, which increases the demand for retail pharmacies. Retail pharmacies' accessibility has a big impact on the segment's growth.
Report Description:
| Attribute | Description |
|---|---|
| Market Size | Revenue (USD Billion) |
| Market size value in 2023 | USD 15.26 Billion |
| Market size value in 2033 | USD 33.26 Billion |
| CAGR (2024 to 2033) | 8.1% |
| Historical data | 2020-2022 |
| Base Year | 2023 |
| Forecast | 2024-2033 |
| Region | The regions examined for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa. |
| Segments | The research segment is based on product type, route of administration, and distribution channel. |
As per The Brainy Insights, the size of the atopic dermatitis market was valued at USD 15.26 billion in 2023 to USD 33.26 billion by 2033.
Global atopic dermatitis market is growing at a CAGR of 8.1% during the forecast period 2024-2033.
The market's growth will be influenced by the growing incidence of skin disorders.
Inadequate understanding of the causes of atopic dermatitis could hamper the market growth.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by Product Type
4.3.2. Market Attractiveness Analysis by Route of Administration
4.3.3. Market Attractiveness Analysis by Distribution Channel
4.3.4. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. The growing incidence of skin disorders
5.3. Restraints
5.3.1. Inadequate understanding of the causes of atopic dermatitis
5.4. Opportunities
5.4.1. Novel biologics and advanced treatment options are being developed by market players
5.5. Challenges
5.5.1. Stringent regulatory approvals and guidelines
6. Global Atopic Dermatitis Market Analysis and Forecast, By Product Type
6.1. Segment Overview
6.2. Corticosteroids
6.3. Calcineurin Inhibitors
6.4. Emollients/Moisturizers
6.5. Antibiotics
6.6. IL-4 and PDE4 Inhibitors
6.7. Others
7. Global Atopic Dermatitis Market Analysis and Forecast, By Route of Administration
7.1. Segment Overview
7.2. Oral
7.3. Topical
7.4. Parenteral
8. Global Atopic Dermatitis Market Analysis and Forecast, By Distribution Channel
8.1. Segment Overview
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
8.5. Others
9. Global Atopic Dermatitis Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Atopic Dermatitis Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in the Atopic Dermatitis Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. AbbVie Inc.
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Allergan Plc.
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. Astellas Pharma Inc.
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. Bristol -Myer Squibb
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Eli Lily and Company
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. Galderma Laboratories LP
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Novartis Pharmaceuticals Corporation
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. Pfizer
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Regeneron Pharmaceuticals Inc.
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Sanofi SA
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
List of Table
1. Global Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
2. Global Corticosteroids Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
3. Global Calcineurin Inhibitors Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
4. Global Emollients/Moisturizers Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
5. Global Antibiotics Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
6. Global IL-4 and PDE4 Inhibitors Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
7. Global Others Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
8. Global Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
9. Global Oral Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
10. Global Topical Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
11. Global Parenteral Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
12. Global Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
13. Global Hospital Pharmacies Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
14. Global Online Pharmacies Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
15. Global Retail Pharmacies Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
16. Global Others Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
17. Atopic Dermatitis Market, By Region, 2020-2033 (USD Billion)
18. North America Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
19. North America Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
20. North America Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
21. U.S. Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
22. U.S. Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
23. U.S. Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
24. Canada Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
25. Canada Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
26. Canada Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
27. Mexico Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
28. Mexico Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
29. Mexico Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
30. Europe Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
31. Europe Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
32. Europe Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
33. Germany Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
34. Germany Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
35. Germany Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
36. France Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
37. France Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
38. France Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
39. U.K. Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
40. U.K. Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
41. U.K. Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
42. Italy Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
43. Italy Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
44. Italy Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
45. Spain Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
46. Spain Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
47. Spain Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
48. Asia Pacific Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
49. Asia Pacific Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
50. Asia Pacific Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
51. Japan Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
52. Japan Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
53. Japan Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
54. China Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
55. China Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
56. China Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
57. India Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
58. India Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
59. India Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
60. South America Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
61. South America Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
62. South America Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
63. Brazil Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
64. Brazil Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
65. Brazil Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
66. Middle East and Africa Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
67. Middle East and Africa Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
68. Middle East and Africa Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
69. UAE Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
70. UAE Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
71. UAE Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
72. South Africa Atopic Dermatitis Market, By Product Type, 2020-2033 (USD Billion)
73. South Africa Atopic Dermatitis Market, By Route of Administration, 2020-2033 (USD Billion)
74. South Africa Atopic Dermatitis Market, By Distribution Channel, 2020-2033 (USD Billion)
List of Figures
1. Global Atopic Dermatitis Market Segmentation
2. Atopic Dermatitis Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Atopic Dermatitis Market Attractiveness Analysis by Product Type
9. Global Atopic Dermatitis Market Attractiveness Analysis by Route of Administration
10. Global Atopic Dermatitis Market Attractiveness Analysis by Distribution Channel
11. Global Atopic Dermatitis Market Attractiveness Analysis by Region
12. Global Atopic Dermatitis Market: Dynamics
13. Global Atopic Dermatitis Market Share by Product Type (2023 & 2033)
14. Global Atopic Dermatitis Market Share by Route of Administration (2023 & 2033)
15. Global Atopic Dermatitis Market Share by Distribution Channel (2023 & 2033)
16. Global Atopic Dermatitis Market Share by Regions (2023 & 2033)
17. Global Atopic Dermatitis Market Share by Company (2023)
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the atopic dermatitis market based on below mentioned segments:
Atopic Dermatitis Market by Product Type:
Atopic Dermatitis Market by Route of Administration:
Atopic Dermatitis Market by Distribution Channel:
Atopic Dermatitis Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date
